158 related articles for article (PubMed ID: 16202062)
1. Remission induction in a Jehovah's witness patient with acute myeloid leukaemia using gemtuzumab ozogamicin.
Bareford D; Odeh B; Narayanan S; Wiltshire S
Transfus Med; 2005 Oct; 15(5):445-8. PubMed ID: 16202062
[TBL] [Abstract][Full Text] [Related]
2. Complete remission induced by gemtuzumab ozogamicin in a Jehovah's Witness patient with acute myelogenous leukemia.
Fujisawa S; Naito K; Matsuoka T; Kobayashi M
Int J Hematol; 2007 Jun; 85(5):418-20. PubMed ID: 17562618
[TBL] [Abstract][Full Text] [Related]
3. Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.
Bross PF; Beitz J; Chen G; Chen XH; Duffy E; Kieffer L; Roy S; Sridhara R; Rahman A; Williams G; Pazdur R
Clin Cancer Res; 2001 Jun; 7(6):1490-6. PubMed ID: 11410481
[TBL] [Abstract][Full Text] [Related]
4. [Successful induction of complete remission by gemtuzumab ozogamicin following chemotherapy in three patients with relapsed or refractory acute myeloid leukemia].
Hirayama Y; Terui T; Koike K; Neda H; Ishitani K; Kohda K; Kuroda H; Iyama S; Sato T; Kobune M; Takimoto R; Kato J
Rinsho Ketsueki; 2009 Aug; 50(8):663-5. PubMed ID: 19915382
[TBL] [Abstract][Full Text] [Related]
5. Addition of gemtuzumab ozogamicin to induction chemotherapy in adult patients with acute myeloid leukaemia: a meta-analysis of individual patient data from randomised controlled trials.
Hills RK; Castaigne S; Appelbaum FR; Delaunay J; Petersdorf S; Othus M; Estey EH; Dombret H; Chevret S; Ifrah N; Cahn JY; Récher C; Chilton L; Moorman AV; Burnett AK
Lancet Oncol; 2014 Aug; 15(9):986-96. PubMed ID: 25008258
[TBL] [Abstract][Full Text] [Related]
6. Gemtuzumab ozogamicin, mitoxantrone, and etoposide in newly diagnosed acute myeloid leukemia patients with persistent leukemia after a course of induction therapy.
Boyiadzis M; Redner RL; Raptis A; Hou JZ; Agha M; Foon KA
Ann Hematol; 2011 Jun; 90(6):733-5. PubMed ID: 20857113
[No Abstract] [Full Text] [Related]
7. Successful treatment with gemtuzumab ozogamicin monotherapy in a pediatric patient with resistant relapse of acute myeloid leukemia.
Unal S; Cakir M; Kuşkonmaz B; Cetin M; Tuncer AM
Turk J Pediatr; 2009; 51(1):69-71. PubMed ID: 19378895
[TBL] [Abstract][Full Text] [Related]
8. Gemtuzumab ozogamicin as maintenance therapy after autologous stem cell transplantation in elderly patients with acute myeloid leukaemia.
Cascavilla N; D'Arena G; Greco MM; Melillo L; Merla E; Carella AM
Br J Haematol; 2008 Sep; 142(5):852-3. PubMed ID: 18510691
[No Abstract] [Full Text] [Related]
9. Clinical and ethical issues in the treatment of a Jehovah's Witness with acute myeloblastic leukemia.
Kerridge I; Lowe M; Seldon M; Enno A; Deveridge S
Arch Intern Med; 1997 Aug 11-25; 157(15):1753-7. PubMed ID: 9250237
[TBL] [Abstract][Full Text] [Related]
10. Effect of gemtuzumab ozogamicin on survival of adult patients with de-novo acute myeloid leukaemia (ALFA-0701): a randomised, open-label, phase 3 study.
Castaigne S; Pautas C; Terré C; Raffoux E; Bordessoule D; Bastie JN; Legrand O; Thomas X; Turlure P; Reman O; de Revel T; Gastaud L; de Gunzburg N; Contentin N; Henry E; Marolleau JP; Aljijakli A; Rousselot P; Fenaux P; Preudhomme C; Chevret S; Dombret H;
Lancet; 2012 Apr; 379(9825):1508-16. PubMed ID: 22482940
[TBL] [Abstract][Full Text] [Related]
11. Acute lymphoblastic leukaemia in a Jehovah's Witness: a management dilemma.
Zhou L; Mohsen A; Khan MA; Guthrie T
J Chemother; 2014 Jun; 26(3):184-6. PubMed ID: 24621157
[TBL] [Abstract][Full Text] [Related]
12. Gemtuzumab ozogamicin plus cytarabine in elderly patients with relapsed or refractory acute myeloid leukaemia.
Doyen J; Italiano A; Peyrade F; Bouyer C; Thyss A
Br J Haematol; 2008 May; 141(5):744-5. PubMed ID: 18373704
[No Abstract] [Full Text] [Related]
13. Gemtuzumab ozogamicin in combination with vorinostat and azacitidine in older patients with relapsed or refractory acute myeloid leukemia: a phase I/II study.
Walter RB; Medeiros BC; Gardner KM; Orlowski KF; Gallegos L; Scott BL; Hendrie PC; Estey EH
Haematologica; 2014 Jan; 99(1):54-9. PubMed ID: 24142996
[TBL] [Abstract][Full Text] [Related]
14. Low dose gemtuzumab ozogamicin for relapsed acute myeloid leukaemia in elderly.
Piccaluga PP; Martinelli G; Rondoni M; Malagola M; Ronconi S; Visani G; Baccarani M
Haematologica; 2003 Dec; 88(12):ECR37. PubMed ID: 14688010
[No Abstract] [Full Text] [Related]
15. Gemtuzumab ozogamicin plus cytarabine determines complete remission in acute myeloid leukemia refractory to a double conventional treatment: a case report.
Mele A; Sparaventi G; Guiducci B; Nicolini G; d'Adamo F; Leopardi G; Delfini C; Piccaluga P; Visani G
Haematologica; 2004 Jun; 89(6 Suppl):ECR18. PubMed ID: 15194554
[No Abstract] [Full Text] [Related]
16. [Long-term complete remission after single therapy with gemtuzumab ozogamicin for refractory AML in an elderly patient].
Ogura K; Machida T; Nara M; Mayama K; Akagi T; Kubo K
Gan To Kagaku Ryoho; 2007 Nov; 34(11):1881-3. PubMed ID: 18030030
[TBL] [Abstract][Full Text] [Related]
17. Preliminary results of the safety of immunotherapy with gemtuzumab ozogamicin following reduced intensity allogeneic stem cell transplant in children with CD33+ acute myeloid leukemia.
Roman E; Cooney E; Harrison L; Militano O; Wolownik K; Hawks R; Foley S; Satwani P; Unal E; Bhatia M; Bradley B; Del Toro G; George D; Garvin J; van de Ven C; Cairo MS
Clin Cancer Res; 2005 Oct; 11(19 Pt 2):7164s-7170s. PubMed ID: 16203817
[TBL] [Abstract][Full Text] [Related]
18. [Molecular target therapy--gemtuzumab ozogamicin].
Usui N
Nihon Rinsho; 2007 Jan; 65 Suppl 1():494-8. PubMed ID: 17474454
[No Abstract] [Full Text] [Related]
19. Decitabine combined with fractionated gemtuzumab ozogamicin therapy in patients with relapsed or refractory acute myeloid leukemia.
Chowdhury S; Seropian S; Marks PW
Am J Hematol; 2009 Sep; 84(9):599-600. PubMed ID: 19650144
[TBL] [Abstract][Full Text] [Related]
20. [Gemtuzumab ozogamicin as monotherapy and combination therapy for acute myelogenous leukemia].
Usui N
Rinsho Ketsueki; 2007 Jun; 48(6):458-67. PubMed ID: 17633093
[No Abstract] [Full Text] [Related]
[Next] [New Search]
